The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 19: 2713 - 2719

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.19.009

Clinical Research

Short⁃term efficacy analysis of platelet⁃rich plasma in arthroscopic rotator cuff repair by comparison of LP⁃PRP and LR⁃PRP

  • Pengshan WANG ,
  • Xiaosong BAI ,
  • Haoran SUN ,
  • Haoxuan LI ,
  • Hongwei CHAI ,
  • Hao LIU ,
  • Hao GUO ,
  • Shuqin ZHU ,
  • Xiaoxin. SUN
Expand
  • Department of Orthopedics，North China University of Science and Technology Affiliated Hospital，Tangshan 063000，Hebei，China

Received date: 2024-03-01

  Online published: 2024-10-22

Fold

Abstract

Objective By comparing with arthroscopic rotator cuff repair alone， to explore the efficacy and difference of leukocyte poor platelet?rich plasma （LP-PRP） and leukocyte rich platelet-rich plasma （LR-PRP） in arthroscopic rotator cuff repair. Methods Sixty patients with total rotator cuff tear accompanied by arthroscopic rotator cuff repair admitted to the Affiliated Hospital of North China University of Science and Technology from October 2021 to September 2022 were included and randomly divided into control group （n = 20）， LP-PRP group （n = 20） and LR-PRP group （n = 20）. The control group only received arthroscopic rotator cuff repair. The LP-PRP group was injected with leukocyte poor platelet-rich plasma （LP-PRP） into the sutured torn tendon after the same operation， and the LR-PRP group was injected with leukocyte rich platelet-rich plasma （LR-PRP） into the sutured torn tendon after the same operation. The postoperative rehabilitation training plan of the three groups was the same， and the postoperative follow-up and evaluation were conducted for 1 year. It included pain score （VAS score）， shoulder joint function score （CMS， UCLA， ASES score）， retear rate and related complications. Results All patients were followed up. （1）VAS score： Compared with the LR-PRP group and the control group， the results were statistically significant only at 1， 3 and 6 weeks after surgery （P < 0.05）； There was no statistical significance between the LR-PRP group and the control group at 1 week， 3 weeks， 6 weeks， 3 months， 6 months and 12 months after surgery（P > 0.05）. （2）CMS， UCLA and ASES scores： There were no significant differences between the LP-PRP group and the LR-PRP group at 3 months， 6 months and 12 months after surgery（P > 0.05）； Compared with LP-PRP group and LR-PRP group， there were significant differences in each follow-up time point of control group （P < 0.05）. （3）Retear rate： In the LP-PRP group， there was 1 retear in the LR-PRP group （tear rate 5%）， and 3 in the control group （tear rate 15%）. There was no statistically significant difference between the three groups（P > 0.05）. （4）There were no postoperative complications in 60 patients. Conclusions Compared with arthroscopic rotator cuff repair alone， although the application of LP-PRP and LR-PRP could not reduce the rate of retear， it could significantly improve the shoulder joint function of patients， and LP-PRP could significantly reduce the pain of patients with rotator cuff injury in the early postoperative period （within 6 weeks）， with no postoperative complications， and the short-term clinical results of patients were satisfactory.

Key words： leukocyte-poor platelet-rich plasma; leukocyte-rich platelet-rich plasma; rotator cuff tear; arthroscope

Cite this article

Pengshan WANG , Xiaosong BAI , Haoran SUN , Haoxuan LI , Hongwei CHAI , Hao LIU , Hao GUO , Shuqin ZHU , Xiaoxin. SUN . Short⁃term efficacy analysis of platelet⁃rich plasma in arthroscopic rotator cuff repair by comparison of LP⁃PRP and LR⁃PRP[J]. The Journal of Practical Medicine, 2024 , 40(19) : 2713 -2719 . DOI: 10.3969/j.issn.1006-5725.2024.19.009

References

1 ZHANG C， WU J， LI X， et al. Current Biological Strategies to Enhance Surgical Treatment for Rotator Cuff Repair ［J］. Front Bioeng Biotechnol， 2021， 9： 657584.
2 BALDWIN M， NAGRA N S， GREENALL G， et al. Use of implantable meshes for augmented rotator cuff repair： A systematic review and meta-analysis ［J］. BMJ Open， 2020， 10（12）： e039552. doi:10.1136/bmjopen-2020-039552
3 BIANCO S T， MOSER H L， GALATZ L M， et al. Biologics and stem cell-based therapies for rotator cuff repair ［J］. Ann N Y Acad Sci， 2019， 1442（1）： 35-47.
4 EVERTS P A M， KNAPE J T A， WEIBRICH G， et al. Platelet-rich plasma and platelet gel： A review ［J］. J Extra Corpor Technol， 2006， 38（2）： 174-187.
5 BAKSH N， HANNON C P， MURAWSKI C D， et al. Platelet-rich plasma in tendon models： A systematic review of basic science literature ［J］. Arthroscopy， 2013， 29（3）： 596-607.
6 BOSWELL S G， COLE B J， SUNDMAN E A， et al. Platelet-rich plasma： A milieu of bioactive factors ［J］. Arthroscopy， 2012， 28（3）： 429-439.
7 MCCARREL T M， MINAS T， FORTIER L A. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy ［J］. J Bone Joint Surg Am， 2012， 94（19）： e143C1-e14318.
8 SUNDMAN E A， COLE B J， FORTIER L A. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma ［J］. Am J Sports Med， 2011， 39（10）： 2135-2140.
9 DOHAN EHRENFEST D M， ANDIA I， ZUMSTEIN M A， et al. Classification of platelet concentrates （Platelet-Rich Plasma-PRP， Platelet-Rich Fibrin-PRF） for topical and infiltrative use in orthopedic and sports medicine： Current consensus， clinical implications and perspectives ［J］. Muscles Ligaments Tendons J， 2014， 4（1）： 3-9.
10 PRODROMOS C C， FINKLE S， PRODROMOS A， et al. Treatment of Rotator Cuff Tears with platelet rich plasma： A prospective study with 2 year follow-up ［J］. BMC Musculoskelet Disord， 2021， 22（1）： 499.
11 ANITUA E， ANDíA I， SANCHEZ M， et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture ［J］. J Orthop Res， 2005， 23（2）： 281-286.
12 MALL N A， TANAKA M J， CHOI L S， et al. Factors affecting rotator cuff healing ［J］. J Bone Joint Surg Am， 2014， 96（9）： 778-788. doi:10.2106/jbjs.m.00583
13 XUE Y， LU T， XU Y， et al. The efficacy of platelet-rich plasma in arthroscopic rotator cuff repair： A protocol of randomized controlled trial ［J］. Medicine， 2020， 99（49）： e23232.
14 YUAN T， GUO S C， HAN P， et al. Applications of leukocyte- and platelet-rich plasma （L-PRP） in trauma surgery ［J］. Curr Pharm Biotechnol， 2012， 13（7）： 1173-1184. doi:10.2174/138920112800624445
15 WYNN T A， VANNELLA K M. Macrophages in Tissue Repair， Regeneration， and Fibrosis ［J］. Immunity， 2016， 44（3）： 450-462.
16 HURLEY E T， HANNON C P， PAUZENBERGER L， et al. Nonoperative Treatment of Rotator Cuff Disease With Platelet-Rich Plasma： A Systematic Review of Randomized Controlled Trials ［J］. Arthroscopy， 2019， 35（5）： 1584-1591. doi:10.1016/j.arthro.2018.10.115
17 RIBOH J C， SALTZMAN B M， YANKE A B， et al. Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis ［J］. Am J Sports Med， 2016， 44（3）： 792-800.
18 SCOTT A， LAPRADE R F， HARMON K G， et al. Platelet-Rich Plasma for Patellar Tendinopathy： A Randomized Controlled Trial of Leukocyte-Rich PRP or Leukocyte-Poor PRP Versus Saline ［J］. Am J Sports Med， 2019， 47（7）： 1654-1661. doi:10.1177/0363546519837954
19 BOHREN Y， TIMBOLSCHI D I， MULLER A， et al. Platelet-rich plasma and cytokines in neuropathic pain： A narrative review and a clinical perspective ［J］. Eur J Pain， 2022， 26（1）： 43-60.
20 ALSOUSOU J， ALI A， WILLETT K， et al. The role of platelet-rich plasma in tissue regeneration ［J］. Platelets， 2013， 24（3）： 173-182.
21 ZHANG J， MIDDLETON K K， FU F H， et al. HGF mediates the anti-inflammatory effects of PRP on injured tendons ［J］. PLoS One， 2013， 8（6）： e67303.
22 RANDELLI P， ARRIGONI P， RAGONE V， et al. Platelet rich plasma in arthroscopic rotator cuff repair： A prospective RCT study， 2-year follow-up ［J］. J Shoulder Elbow Surg， 2011， 20（4）： 518-528. doi:10.1016/j.jse.2011.02.008
23 HOLTBY R， CHRISTAKIS M， MAMAN E， et al. Impact of Platelet-Rich Plasma on Arthroscopic Repair of Small- to Medium-Sized Rotator Cuff Tears： A Randomized Controlled Trial ［J］. Orthop J Sports Med， 2016， 4（9）： 2325967116665595. doi:10.1177/2325967116665595
24 D'AMBROSI R， PALUMBO F， PARONZINI A， et al. Platelet-rich plasma arthroscopic repair of full-thickness rotator cuff tears： A randomized clinical trial ［J］. Musculoskelet Surg， 2016， 100（Suppl 1）： 25-32.
25 SHARMA P， MAFFULLI N. Biology of tendon injury： Healing， modeling and remodeling ［J］. J Musculoskelet Neuronal Interact， 2006， 6（2）： 181-190.
26 HURLEY E T， COLASANTI C A， ANIL U， et al. The Effect of Platelet-Rich Plasma Leukocyte Concentration on Arthroscopic Rotator Cuff Repair： A Network Meta-analysis of Randomized Controlled Trials ［J］. Am J Sports Med， 2021， 49（9）： 2528-2535. doi:10.1177/0363546520975435
Options
Outlines

/

〈 〉